EBQ:Japanese OHCA Prehospital Airway Management Trial: Difference between revisions

Line 49: Line 49:
*Favorable neurological outcome at 1 month after cardiac arrest
*Favorable neurological outcome at 1 month after cardiac arrest
**Favorable neurological outcome considered a Glasgow-Pittsburgh cerebral performance category of 1 or 2
**Favorable neurological outcome considered a Glasgow-Pittsburgh cerebral performance category of 1 or 2
**Overall: 2.2%
**BVM: 2.9%
**Advanced Airway: 1.1%
***Endotracheal Intubation: 1.0%
***Supraglottic Airway: 1.1%
**Odds Ratio (95% CI) Advanced Airway vs. BVM: 0.38 (0.36-0.39)
*Glasgow-Pittsburgh cerebral performance categories:
*Glasgow-Pittsburgh cerebral performance categories:
**Category 1 (good performance)
**Category 1 (good performance)

Revision as of 15:45, 14 October 2019

incomplete Journal Club Article
Hasegawa, K et al. "Association of Prehospital Advanced Airway Management With Neurologic Outcome and Survival in Patients With Out-of-Hospital Cardiac Arrest". JAMA. 2012. 309 (3)(187612):257–266.
PubMed Full text PDF

Clinical Question

  • Do patients with out of hospital cardiac arrest have more favorable neurological outcome with advanced airway management by EMS compared to conventional bag-valve-mask ventilation?
  • Authors hypothesized that both supraglottic and endotracheal intubation would be associated with more favorable neurologic outcomes.

Conclusion

  • Advanced airway of any type was independently associated with decreased odds of neurologically favorable survival compared to BVM ventilation

Major Points

Inclusion Criteria

  • January 1, 2005 to December 31, 2010
  • Japanese EMS database
  • 18 years older who had out of hospital cardiac arrest
  • Resuscitation was attempted by EMS and patient was transported to hospital


Exclusion Criteria

  • No age recorded for cardiac arrest
  • Out of hospital airway management not documented

Interventions

  • Advanced airway devices placed by EMTs
    • Endotracheal intubation
    • Supraglottic airway
      • Laryngeal mask airway, laryngeal tube, or esophageal-tracheal twin lumen airway device
  • Providers had 2 attempts to place airway device
  • Advanced airway confirmed with end-tidal CO2 and/or esophageal detection device

Outcome

Primary Outcomes

  • Favorable neurological outcome at 1 month after cardiac arrest
    • Favorable neurological outcome considered a Glasgow-Pittsburgh cerebral performance category of 1 or 2
    • Overall: 2.2%
    • BVM: 2.9%
    • Advanced Airway: 1.1%
      • Endotracheal Intubation: 1.0%
      • Supraglottic Airway: 1.1%
    • Odds Ratio (95% CI) Advanced Airway vs. BVM: 0.38 (0.36-0.39)
  • Glasgow-Pittsburgh cerebral performance categories:
    • Category 1 (good performance)
    • Category 2 (moderate disability)
    • Category 3 (severe disability)
    • Category 4 (vegetative state)
    • Category 5 (death)

Secondary Outcomes

  • Return of spontaneous circulation before hospital arrival
    • Overall: 6.5%
    • BVM: 7.0%
    • Advanced Airway: 5.8%
      • Endotracheal Intubation: 8.4%
      • Supraglottic Airway: 5.3%
  • One-month survival
    • Overall 4.7%
    • BVM: 5.3%
    • Advanced Airway: 3.9%
      • Endotracheal Intubation: 4.2%
      • Supraglottic Airway: 3.8%

Subgroup analysis

  • Advanced airway versus bag-valve-mask ventilation
  • Endotracheal intubation or supraglottic airway versus bag-valve-mask ventilation

Criticisms

  • Not a randomized and there is potential selection bias and confounding
  • Generalization difficult for U.S. based EMS given different training for EMT's, different population, and different protocols

Funding

References